Precision BioScience Secures $25,600,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0dc8b7b-49e5-4853-84b2-e08d3b2e7ff4 - Date
5/12/2015 - Company Name
Precision BioScience - Mailing Address
302 East Pettigrew St. Durham, NC 27701 USA - Company Description
Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome. - Website
http://www.precisionbiosciences.com - Transaction Type
Venture Equity - Transaction Amount
$25,600,000 - Transaction Round
Series A - Proceeds Purposes
This financing will allow us to expand beyond our successful efforts to develop the leading next-gen genome editing platform and significantly accelerate the development of our genome-edited product pipeline. - M&A Terms
- Venture Investor
- Venture Investor
